肖汀 Ting Xiao

探究恶性肿瘤发生发展的分子机制和分子标志，聚焦临床蛋白质组学，致力于发掘肿瘤诊疗、预后监测的生物标志物，发现新型抗肿瘤药物靶点，注重科研成果向临床应用转化。

Exploring the molecular mechanisms and molecular markers of malignant tumor occurrence and development, focusing on clinical proteomics, dedicated to discovering biomarkers for tumor diagnosis, treatment and prognosis monitoring, discovering novel anti-tumor drug targets, and emphasizing the translation of research results into clinical applications.